Evidence map›Paper›PMID 27909057›Full record

ArticleThe Journal of biological chemistry2017

Structure of the Toll/Interleukin-1 Receptor (TIR) Domain of the B-cell Adaptor That Links Phosphoinositide Metabolism with the Negative Regulation of the Toll-like Receptor (TLR) Signalosome.

Samer Halabi, Eiki Sekine, Brett Verstak, Nicholas J Gay, Martin C Moncrieffe

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Pharmacological Mechanisms of Shangke Huangshui against Skin and Soft Tissue Infection.Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  10. Antimicrobial peptides could antagonize uncontrolled inflammationFrontiers in bioengineering and biotechnology · 2022
    Review
  11. Review
  12. TIRAP in the Mechanism of Inflammation.Frontiers in immunology · 2021
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Samer HalabiFrom the Department of Biochemistry, Cambridge University, Cambridge CB2 1GA, United Kingdom.
Eiki SekineFrom the Department of Biochemistry, Cambridge University, Cambridge CB2 1GA, United Kingdom.
Brett VerstakFrom the Department of Biochemistry, Cambridge University, Cambridge CB2 1GA, United Kingdom.
Nicholas J GayFrom the Department of Biochemistry, Cambridge University, Cambridge CB2 1GA, United Kingdom njg11@cam.ac.uk.
Martin C MoncrieffeFrom the Department of Biochemistry, Cambridge University, Cambridge CB2 1GA, United Kingdom mcm35@cam.ac.uk.
University of Cambridge · GB

Funding

Medical Research Council G1000133Wellcome Trust
6 · The paper itself

Abstract

Ligand binding to Toll-like receptors (TLRs) results in dimerization of their cytosolic Toll/interleukin-1 receptor (TIR) domains and recruitment of post-receptor signal transducers into a complex signalosome. TLR activation leads to the production of transcription factors and pro-inflammatory molecules and the activation of phosphoinositide 3-kinases (PI3K) in a process that requires the multimodular B-cell adaptor for phosphoinositide 3-kinase (BCAP). BCAP has a sequence previously proposed as a "cryptic" TIR domain. Here, we present the structure of the N-terminal region of human BCAP and show that it possesses a canonical TIR fold. Dimeric BCAP associates with the TIR domains of TLR2/4 and MAL/TIRAP, suggesting that it is recruited to the TLR signalosome by multitypic TIR-TIR interactions. BCAP also interacts with the p85 subunit of PI3K and phospholipase Cγ, enzymes that deplete plasma membrane phosphatidylinositol 4,5-bisphosphate (PIP2), and these interactions provide a molecular explanation for BCAP-mediated down-regulation of inflammatory signaling.

Indexed as

Protein MultimerizationSignal TransductionCarrier ProteinsHumansMembrane GlycoproteinsMyelin and Lymphocyte-Associated Proteolipid ProteinsPhosphatidylinositol 3-KinasesPhosphatidylinositol 4,5-DiphosphateProtein DomainsReceptors, Interleukin-1Toll-Like Receptor 2Toll-Like Receptor 4Carrier ProteinsMAL protein, humanMembrane GlycoproteinsMyelin and Lymphocyte-Associated Proteolipid ProteinsODF2L protein, humanPhosphatidylinositol 3-KinasesPhosphatidylinositol 4,5-DiphosphateReceptors, Interleukin-1TIRAP protein, humanTLR2 protein, humanTLR4 protein, humanToll-Like Receptor 2Toll-Like Receptor 4BCAPBCAP adaptorcrystal structureMAL/TIRAPpathway crosstalkphosphatidylinositide 3-kinase (PI 3-kinase)phosphatidylinositol 4,5-bisphosphatephospholipase CPI3 kinasePLCγ2TIR domainToll-like receptorToll-like receptor (TLR)

Identifiers

PMID27909057
PMCPMC5241739
OpenAlexW2559445021

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.